Treatment of breast cancer cell lines with the LDH-A inhibitor oxamate and taxol resulted in a synergistic inhibitory effect on taxol resistant cancer cells by promoting apoptosis in these cells (133). This evidence concerns the gene LDHA and breast carcinoma.